IMMUNE ONCIA THERAPEUTICS INC. Trademark
Trademark Overview
On Tuesday, December 31, 2024, a trademark application was filed for IMMUNE ONCIA THERAPEUTICS INC. with the United States Patent and Trademark Office. The USPTO has given the IMMUNE ONCIA THERAPEUTICS INC. trademark a serial number of 79418671. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, March 6, 2025. This trademark is owned by ImmuneOncia Therapeutics, Inc.. The IMMUNE ONCIA THERAPEUTICS INC. trademark is filed in the Pharmaceutical Products category with the following description:
Drugs for medical purposes; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumours; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for health care; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating t...

General Information
Serial Number | 79418671 |
Word Mark | IMMUNE ONCIA THERAPEUTICS INC. |
Filing Date | Tuesday, December 31, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Thursday, March 6, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 0 - NOT AVAILABLE |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Drugs for medical purposes; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical preparations for treating malignant tumours; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for health care; pharmaceutical preparations for immunity adjustment; pharmaceutical preparations for regulating the immune system; anti-cancer preparations; tumor suppressing agents; medical and surgical plasters; adhesive plasters. |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, March 6, 2025 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | ImmuneOncia Therapeutics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | KR |
Trademark Events
Event Date | Event Description |
Thursday, March 6, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |